Paediatricians Call for Ban on Disposable Vapes in UK

Jun.07.2023
Paediatricians Call for Ban on Disposable Vapes in UK
UK pediatricians call for ban on disposable vapes to protect youth from unknown long-term health effects.

On June 6th, The Guardian reported that the Royal College of Paediatrics and Child Health (RCPCH) in the UK is calling for a total ban on disposable e-cigarettes in order to reduce their popularity among young people. This is because the long-term effects of e-cigarettes on the lungs, heart, and brain are still unknown. However, the UK Vaping Industry Association (UKVIA) agrees with some of RCPCH's views but believes that banning disposable e-cigarettes is not the solution.

 

It is necessary to ban disposable electronic cigarette products.

 

The Royal College of Pediatrics and Child Health has stated that the government should ban the sale of disposable e-cigarettes priced at £1.99, as they are particularly popular among young people.

 

This will reduce the impact of e-cigarettes on the environment and prevent children who have never smoked from using them, thereby avoiding the risks of long-term addiction and lung damage.

 

Dr. Mike McKean, Vice-President of the Royal College of Pediatrics and Child Health, has expressed concern over the "epidemic of child smoking," long-term health impacts research, and the increasing number of children with respiratory issues. The college has issued a "carefully considered call to action" on these issues.

 

McCain stated that it took decades to understand the link between smoking and cancer and respiratory diseases. He expressed concern that people may act blindly on this issue.

 

Currently, we have not seen a large number of severely damaged lungs, but there have been reports indicating extremely severe inflammation reactions leading to permanent scarring.

 

He stated that while he believed Australia's approach (allowing e-cigarettes to be purchased only with a prescription) might burden the national healthcare system, England's lenient approach is "incommensurate" with neighboring countries such as Scotland, France, Germany, and Ireland.

 

Banning disposable e-cigarettes is not the solution.

 

The UK Vaping Industry Association (UKVIA) has responded to the call from the Royal College of Pediatrics and Child Health on its official website. The statement by the UKVIA indicates its agreement with the Royal College of Pediatrics and Child Health's point of view and believes that steps should be taken to address the issues of underage electronic cigarette use and environmental impact. However, banning disposable e-cigarettes is not a solution.

 

England has banned the free distribution of e-cigarette samples to individuals under the age of 18 and may also prohibit colorful packaging and flavor labeling targeted towards young people.

 

The UKVIA believes that the solution is not to ban any type of e-cigarette product, thereby depriving adult smokers of an effective choice, especially those people in high smoking rate and low-income areas. Instead, they advocate for ensuring that regulations are strict enough and penalties are harsh enough to ensure that rogue retailers are hit hard when they sell to minors for the first time.

 

The UK Vaping Industry Association (UKVIA) is calling on the government to take strict measures, including:

 

Individuals found violating regulations by selling illegal products or selling to young people will now face an on-site penalty fine of at least £10,000 (up from £2,500); the implementation of a retail registration scheme will ensure that retailers meet strict standards before being allowed to sell e-cigarettes, including rigorous age verification processes; and a nationwide test purchasing scheme will ensure that businesses selling e-cigarettes under the registration scheme do not supply products to minors, similar to the program between UKVIA and its members.

 

John Dunne, General Secretary of UKVIA, stated:

 

Strongly cracking down on businesses that sell electronic cigarette products to children is the way forward for the future.

 

It has been reported that 1.3 million electronic cigarettes are discarded each week in the UK. The latest official data shows that 1 in 5 15-year-olds used e-cigarettes in 2021. Data from Public Health England indicates that the use of e-cigarettes among teenagers aged 11 to 17 has increased by 50% compared to last year.

 

A spokesperson from the UK Department of Health and Social Care stated:

 

Selling nicotine e-cigarettes to minors is illegal, and we are concerned about the rising number of young people smoking, especially because the long-term harm is still unclear.

 

 

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
The Irish presidency of the Council of the European Union is using bilateral talks to push the bloc’s Tobacco Taxation Directive toward a political agreement in November. According to Law360, citing an EU official, Sweden is unwilling to accept a minimum excise threshold above €20 per kilogram for nicotine pouches. Council negotiations have already lowered the European Commission’s original proposal, but a May 2026 presidency compromise still set the minimum at 10% of the tax-inclusive retail price or €30 per kilogram in 2028-29, with higher levels later.
Market
Sep.17 by 2Firsts Perspectives
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives